US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 3.0400
  • +0.2700+9.75%
Close Apr 25 16:00 ET
8.24MMarket Cap-1351P/E (TTM)

About Cyclerion Therapeutics Company

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Company Profile

SymbolCYCN
Company NameCyclerion Therapeutics
Listing DateMar 18, 2019
Founded2018
CEOMs. Regina Margaret Graul, PhD
MarketNASDAQ
Employees1
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressRiverview II,245 First Street,18th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-327-8778
Websitehttp://www.cyclerion.com

Company Executives

  • Name
  • Position
  • Salary
  • Rhonda Chicko
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Regina Margaret Graul, PhD
  • President and Principal Executive Officer
  • --
  • Dr. Peter M. Hecht, PhD
  • Director
  • 590.26K
  • Dr. Steven E. Hyman, M.D.
  • Independent Director
  • 52.64K
  • Terrance G. Mcguire
  • Independent Director
  • 59.03K
  • Dr. Dina Katabi, M.S.,PhD
  • Independent Director
  • --
  • Michael J. Higgins
  • Independent Director
  • --
  • Dr. Errol B. De Souza,PhD
  • Independent Director
  • 58.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg